GelStat Corp. (GSAC)
OTCMKTS
· Delayed Price · Currency is USD
0.0004
0.00 (0.00%)
Jun 16, 2025, 9:52 AM EDT
GelStat Revenue
In the year 2024, GelStat had annual revenue of $349.73K with 133.89% growth. GelStat had revenue of $117.25K in the quarter ending December 31, 2024, with 87.78% growth.
Revenue
349.73K
Revenue Growth
+133.89%
P/S Ratio
4.28
Revenue / Employee
174.87K
Employees
2
Market Cap
1.50M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 349.73K | 200.20K | 133.89% |
| Dec 31, 2023 | 149.53K | 147.19K | 6,309.22% |
| Dec 31, 2022 | 2.33K | -4.69K | -66.78% |
| Dec 31, 2021 | 7.02K | 3.07K | 77.77% |
| Dec 31, 2020 | 3.95K | - | - |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
| Dec 31, 2013 | Pro | Pro | Pro |
| Dec 31, 2012 | Pro | Pro | Pro |
| Dec 31, 2011 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo, Inc. | 1.73B |
| Veradigm | 588.02M |
| Elite Pharmaceuticals | 70.00M |
| Tian'an Technology Group | 1.78M |
| Northwest Biotherapeutics | 1.47M |
| Glass House Brands | 215.62M |
| American Oncology Network | 1.76B |
| Silence Therapeutics | 27.70M |
GelStat News
- 7 days ago - GSAC Engineering Secures Multi-Year Recurring Revenue Contract - GlobeNewsWire
- 1 year ago - GSAC Engineering Acquires Key Intellectual Property and Assets from Duos Technologies Group - GlobeNewsWire
- 2 years ago - GelStat Forms New and Advanced Engineering Division - GlobeNewsWire
- 3 years ago - GelStat Provides Corporate Update on Capital Restructuring - GlobeNewsWire